Cathepsin-k expression in pulmonary lymphangioleiomyomatosis - Wikidata - awgldk - TriplyDB

Cathepsin-k expression in pulmonary lymphangioleiomyomatosis

Cathepsin-k expression in pulmonary lymphangioleiomyomatosis

http://www.wikidata.org/entity/Q57786833

about

mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the "perfect storm" of pro-metastatic factors in LAM pathogenesis The expression and activity of cathepsins D, H and K in asthmatic airways.Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy Multiplex zymography captures stage-specific activity profiles of cathepsins K, L, and S in human breast, lung, and cervical cancer Wild type mesenchymal cells contribute to the lung pathology of lymphangioleiomyomatosis Lymphangioleiomyomatosis: what do we know and what are we looking for?Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex.Lymphangioleiomyomatosis - a wolf in sheep's clothing.Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm Faslodex inhibits estradiol-induced extracellular matrix dynamics and lung metastasis in a model of lymphangioleiomyomatosis.A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.A broad survey of cathepsin K immunoreactivity in human neoplasms.Soft tissue tumors of uncertain origin.Lung cryobiopsies: a paradigm shift in diagnostic bronchoscopy?Pneumonitis and pulmonary fibrosis associated with breast cancer treatments.Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.Lymphangioleiomyomatosis, multifocal micronodular pneumocyte hyperplasia, and sarcoidosis: more pathological findings in the same chest CT, or a single pathological pathway?Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis.Emerging biomarkers of lymphangioleiomyomatosis.Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.[A clinicopathological analysis of pulmonary lymphangioleiomyomatosis].β-Catenin Is a Useful Adjunct Immunohistochemical Marker for the Diagnosis of Pulmonary Lymphangioleiomyomatosis The efficacy and adverse events of mTOR inhibitors in lymphangioleiomyomatosis: systematic review and meta-analysis

P2860

Q28751693-D71FDEE5-6CC4-4225-9C4D-9C9B64922720 Q34618287-3C25080E-FB29-429C-A0CD-C40BC58998D0 Q35044713-FE77CFB3-BED8-467C-AADB-8C9F82535D2C Q35107703-96233582-7C6C-47DE-BAD4-606A4DE0A4B8 Q35137318-CE8D6E25-34DF-4A76-B3D2-FB4F0EF242D0 Q35610828-F9884246-04E8-43EE-88E0-AE13914E6590 Q36067383-1AAA027B-D3C9-4F7F-A876-1DF3364E1B12 Q36210035-D436AED7-4DD6-45E8-B719-7D1227B83EBB Q36357766-435F6171-60D9-481B-8EC9-DA10E90AADF9 Q36755080-61CFEA35-77B0-4E7B-9922-C4754B52BC8F Q37056468-A0203D3A-8E16-4665-A67A-B0DEB0179BC8 Q37241549-2AB0157F-086A-4B31-BF19-709CA6750059 Q37397803-6EC6A6BB-1433-4788-B69C-FB90FA0443ED Q37642557-53F06898-FBFD-42DA-AABA-CB235C1F43DB Q37993931-D69219EC-78D7-4419-9FD5-A998C531D9E9 Q38214977-EDC46AB9-C992-41B6-8732-181BF080B387 Q38220276-43D4CEB6-EEAD-4173-A3CC-E2C35BDC60C0 Q38895095-F8D46250-12E4-4EC6-A420-44B8664F3AA9 Q42339313-5AA4E700-87D4-4C22-8B06-9628CA91B140 Q48207468-AFF9164F-703F-43E0-8DB0-DC1EE83199D8 Q49679457-07821A89-9156-4D56-80B9-B2647D634DCD Q53246289-D948FEE0-2991-4EE6-9B93-9BA38DFE25C8 Q55464703-45B10A66-0A94-4C9A-A786-FAEF9C5A1886 Q57165782-72475296-D4FF-4AB0-9E53-434089A26AD6 Q58782491-86FC4882-8DE4-4C21-8421-085F122DDA0B

P2860

Cathepsin-k expression in pulmonary lymphangioleiomyomatosis

http://www.wikidata.org/entity/Q57786833

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2008

@uk

name

Cathepsin-k expression in pulmonary lymphangioleiomyomatosis

@en

Cathepsin-k expression in pulmonary lymphangioleiomyomatosis

@nl

type

label

Cathepsin-k expression in pulmonary lymphangioleiomyomatosis

@en

Cathepsin-k expression in pulmonary lymphangioleiomyomatosis

@nl

prefLabel

Cathepsin-k expression in pulmonary lymphangioleiomyomatosis

@en

Cathepsin-k expression in pulmonary lymphangioleiomyomatosis

@nl

P1433

Q57786833-9CFE015E-82B7-46DE-93BE-17390AA029C1

P1476

Q57786833-EB67310C-463E-456B-9679-CB91150A9252

P2093

Q57786833-26D239F5-5286-4996-9F0C-C033E5142629

Q57786833-3C386D19-A2FF-4CFE-814E-69A4151FA87F

Q57786833-46BE381D-7D2A-4DDF-9A35-1F842088FA06

Q57786833-B678BF00-A454-4D56-8B7C-80B3668E8950

Q57786833-F16E85E5-1A6A-4971-B23C-8F271FBD4C88

P2860

Q57786833-01DBA63C-78EE-45DA-A259-C081A85BC473

Q57786833-0A8201EE-1129-4643-A6FA-9FA984112FA4

Q57786833-0BEA2920-FC65-424F-953C-76EA0BAD8594

Q57786833-15AD2347-1D0C-4581-A8E3-26CFB41126D4

Q57786833-17A77A8A-CDAE-4AAF-978C-4FE5F466CB79

Q57786833-1B7C26BC-8698-4893-A886-42629EA8E1B9

Q57786833-4A7D73EF-AF6D-4CE2-83E6-E01284B5D2CF

Q57786833-4E69BB3B-01FF-4D3C-AEC8-5108DF32B2F4

Q57786833-6E9E3E1D-86FA-4C68-8649-0E7D3F918054

Q57786833-70BC8566-FB7F-4216-BA34-73DD9CB22F49

P2888

Q57786833-8A81F720-5731-43D9-9BA6-0F8FFDE0F070

P304

Q57786833-059764EA-1505-4F1B-ACBA-BE6B3D283F83

P31

Q57786833-564FECC9-D1DB-4E09-95E8-107F4F40B1BC

P356

Q57786833-5597CE33-1E52-43CD-9AF0-F7679F897881

P433

Q57786833-714B7F4D-451A-42C4-8C3C-0F5BD33CFA5B

P478

Q57786833-D43495A0-ED0C-4B29-81C2-5E9CF5E7381D

P50

Q57786833-06ED9A5F-272B-4061-A244-713F077FB571

Q57786833-F39FFF29-171C-4916-BA4F-1DCDEFFB9213

P577

Q57786833-9A18E437-F8EA-4766-B2D5-C9F9283C734B

P6179

Q57786833-E1AC7C72-9267-4349-A605-6D911075BDAD

P698

Q57786833-1EF8DF72-D262-4CA7-9C76-1E19F271E607

P356

MODPATHOL.2008.189

P1433

Modern Pathology

P1476

Cathepsin-k expression in pulmonary lymphangioleiomyomatosis

@en

P2093

Franco Bonetti

http://www.w3.org/2001/XMLSchema#string

Guido Martignoni

http://www.w3.org/2001/XMLSchema#string

Marco Chilosi

http://www.w3.org/2001/XMLSchema#string

Matteo Brunelli

http://www.w3.org/2001/XMLSchema#string

Maurizio Pea

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone

PEComas: the past, the present and the future

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

Identification and characterization of the tuberous sclerosis gene on chromosome 16

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis

Tuberous sclerosis: from tubers to mTOR.

Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis.

Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.

Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family

Pivotal role of cathepsin K in lung fibrosis.

P2888

modpathol.2008.189

P304

161-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2008.189

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Venerino Poletti

P577

2008-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1001948057

http://www.w3.org/2001/XMLSchema#string

P698

19060845

http://www.w3.org/2001/XMLSchema#string